CareLit · DOI-Nachweis · Pneumologie
The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD
DOI 10.1055/s-0036-1572051
Bibliografische Angaben
Nachweis in CareLit
Autor:innenC Priegnitz, GT Ferguson, E Pizzichini, M Flezar, L Grönke, L Korducki
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Tiotropium (T) is an established once-daily long-acting muscarinic antagonist that improves the main functional and patient-orientated outcomes of COPD. The long-acting ß2-agonist olodaterol (O) has a rapid onset of action (5 mins post-dose) providing 24-h bronchodilation in patients with COPD.1 The TONADO studies investigated the efficacy and safety of the fixed-dose combination (FDC) of T and O over 1…
Zitieren
Zitierempfehlung
C Priegnitz, GT Ferguson, E Pizzichini, M Flezar, L Grönke, L Korducki (2016) The fixed-dose combination of tiotropium + olodaterol has a rapid onset of action in patients with COPD. Pneumologie (02). https://doi.org/10.1055/s-0036-1572051
Mit CareLit weiterarbeiten